Idexx Laboratories reported $1.51B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
Align Technology USD 2.66B 7.62M Jun/2026
AngioDynamics USD 161.35M 4.69M Sep/2025
Dentsply International USD 1.85B 178M Mar/2026
Dexcom USD 4.09B 245.1M Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
Fujifilm JPY 1.72T 2.2B Mar/2026
Globus Medical USD 2.2B 72.51M Mar/2026
Henry Schein USD 4.6B 104M Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 19.46M Jun/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
Neogen USD 604.6M 14.6M Mar/2026
Orthofix International USD 446.13M 15.39M Jun/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Steris USD 2.39B 108.4M Mar/2026
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Zoetis USD 6.47B 294M Mar/2026